Hybrid Pharma Packaging Partner (HP3) is a change programme designed to accelerate the competitiveness of the pharmaceutical primary packaging industry by raising the performance of its supply chains.
We have a team of expert primary pharmaceutical packaging designers who can assist you in your next NPD project. From adapting current devices to be child safe compliant or a brand new closure to eradicate evaporation, our NPD team will assist.
A team dedicated to designing child resistant compliant primary pharmaceutical packaging and devices. Whether that is an existing piece of packaging or a new product, the team will partner with you to achieve your primary packaging objectives.
Origin Pharma Packaging explains their dynamic pharmaceutical packaging design process and the importance of getting your primary packaging design right, the first time around.
Origin Pharma Packaging launching one of two PP28 (child resistant) closure developments at CPhI Barcelona